[Prevention of cardiovascular disease in type 2 diabetic patients].
Cardiovascular morbidity is a major burden in patients with type 2 diabetes. Many national guidelines for the treatment of type 2 diabetes recommend reducing the risk of multiple factors through the use of protocols and therapeutic targets. The current several important studies suggests that a long-term, targeted, intensive intervention involving multiple risk factors reduces the risk of both cardio-cerebro-vascular and microvascular events among patients with type 2 diabetes.
Yokota
Chizuko
C
Fourth Department of Internal Medicine, Saitama Medical School.
D000959:Antihypertensive Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D012306:Risk; D012307:Risk Factors; D019821:Simvastatin / Q000627:therapeutic use
D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D019821:Simvastatin